Ashland Inc. (ASH) Balance Sheet

As reported in recent financial statements, Ashland's total assets have declined from $5.9 billion in 2024Q1 to $4.5 billion by 2026Q2, a trend that reflects the company's strategic divestiture of non-core business units to sharpen its focus on specialty ingredients and life sciences.

Based on the provided quarterly data, Ashland has maintained a disciplined debt-to-equity ratio, which stood at 0.79 as of 2026Q2, indicating that management has successfully utilized divestiture proceeds to keep leverage within a manageable range despite the volatility in its underlying operational performance.

According to historical balance sheet filings, goodwill has been reduced from $1.4 billion in 2024Q4 to $700 million in 2026Q2, signaling a significant write-down of intangible assets that likely stems from the company's transition away from legacy industrial chemical operations toward higher-margin specialty markets.

As indicated by the most recent quarterly filings, Ashland maintains a current ratio of 3.06, which suggests a robust liquidity position that provides the company with significant flexibility to navigate short-term operational headwinds and fund its ongoing capital allocation priorities without immediate reliance on external credit.